REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC
14/06/2021 11:20
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210614:nBw6zZwBFa&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 11 June 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,879,819 1.46% 231,625 0.18%
(2) Derivatives (other than options):
72,359 0.06% 94,581 0.07%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,958,278 1.52% 332,306 0.26%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 256.5200 USD
Purchase 1 258.8200 USD
Purchase 1 259.1400 USD
Purchase 1 257.5000 USD
Purchase 2 256.8400 USD
Purchase 5 256.7800 USD
Purchase 6 257.0900 USD
Purchase 12 257.2150 USD
Purchase 12 257.1250 USD
Purchase 13 256.7750 USD
Purchase 14 257.3400 USD
Purchase 16 259.0325 USD
Purchase 18 257.1733 USD
Purchase 20 257.1055 USD
Purchase 22 257.0500 USD
Purchase 22 257.0686 USD
Purchase 28 257.3246 USD
Purchase 28 257.2653 USD
Purchase 34 257.8900 USD
Purchase 36 257.1077 USD
Purchase 42 257.3071 USD
Purchase 50 256.8600 USD
Purchase 100 257.7200 USD
Purchase 100 256.6100 USD
Purchase 100 256.8054 USD
Purchase 108 256.8000 USD
Purchase 260 257.1943 USD
Purchase 268 258.6462 USD
Purchase 283 257.6414 USD
Purchase 303 258.2385 USD
Purchase 368 257.0490 USD
Purchase 372 258.1951 USD
Purchase 373 257.7167 USD
Purchase 581 257.4912 USD
Purchase 792 257.4017 USD
Purchase 931 258.1352 USD
Purchase 977 257.9064 USD
Purchase 2,204 257.7030 USD
Purchase 2,809 257.5012 USD
Purchase 3,352 257.6378 USD
Purchase 5,021 257.8599 USD
Purchase 5,701 258.7173 USD
Purchase 8,053 257.9764 USD
Purchase 9,191 257.4900 USD
Purchase 9,749 258.1731 USD
Purchase 10,508 257.6878 USD
Purchase 14,500 257.6789 USD
Sale 6 257.6191 USD
Sale 8 257.4712 USD
Sale 11 257.4354 USD
Sale 13 256.9000 USD
Sale 13 256.9700 USD
Sale 13 257.1300 USD
Sale 14 257.4407 USD
Sale 16 257.4800 USD
Sale 16 257.5493 USD
Sale 19 257.5868 USD
Sale 20 257.1700 USD
Sale 21 257.5659 USD
Sale 25 257.7520 USD
Sale 25 257.6034 USD
Sale 26 256.8500 USD
Sale 26 257.0800 USD
Sale 26 256.7750 USD
Sale 33 257.8683 USD
Sale 34 257.8900 USD
Sale 61 258.7600 USD
Sale 80 257.1721 USD
Sale 82 256.7900 USD
Sale 90 258.9633 USD
Sale 100 257.0900 USD
Sale 111 257.6100 USD
Sale 184 257.0490 USD
Sale 298 258.0470 USD
Sale 510 258.1390 USD
Sale 520 257.1943 USD
Sale 603 257.5332 USD
Sale 1,416 257.4021 USD
Sale 1,689 257.6495 USD
Sale 2,104 257.7322 USD
Sale 2,623 257.4968 USD
Sale 2,842 257.5479 USD
Sale 11,682 257.6981 USD
Sale 11,778 258.3941 USD
Sale 17,332 257.4900 USD
Sale 23,773 258.0053 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 14 Jun 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210614005334/en/
(https://www.businesswire.com/news/home/20210614005334/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Willis Towers Watson
See all newsREG - Onward Opportunities - Admission to AIM and First Day of Dealings
AnnouncementRCS - Brit Utd ProvAscBUPA - Directorate Change - Nicholas Lyons
AnnouncementREG - BkofA Merrill Lynch Willis Towers Watson - Form 38.5 (a) - Willis Towers Watson Plc
AnnouncementREG - BkofA Merrill Lynch Willis Towers Watson - Form 38.5 (b) - Willis Towers Watson Plc
AnnouncementREG - BkofA Merrill Lynch Willis Towers Watson - Form 38.5 (b) - Willis Towers Watson Plc
Announcement